Inorganic–polymer composites have become promising materials to be processed by printing technologies because of their unique properties that allow the fabrication of flexible wearable electronics at reduced manufacturing costs. In the present work, a complete methodological process of assembling a flexible microthermoelectric generator based on inorganic−polymer materials is presented. The used microparticles were prepared by a top-down approach beginning with a previously prepared material by solid-state reaction and later scaled down through the use of ball milling. It was found that the necessity to proceed with a chemical treatment with HCl to reduce Bi2O3 present on the surface of the microparticle leads to a power factor (PF) of 2.29 μW K–2 m–1, which is two times higher than that of the untreated sample. On the fabrication of flexible inorganic–organic thermoelectric thick films based on Bi2Te3 microparticles (<50 μm) and the poly­(vinyl alcohol) (PVA) polymer with different thicknesses ranging from 11 to 265 μm and with different Bi2Te3 weight percentages (wt %), we found that PVA allowed achieving a homogeneous dispersion of the parent inorganic thermoelectric materials, while still maintaining their high performance. The best produced ink was obtained with 25 wt % of PVA and 75 wt % of chemically treated Bi2Te3 micropowder with a Seebeck coefficient of −166 μV K–1 and a PF of 0.04 μW K–2 m–1. For this optimized concentration, a flexible thermoelectric device was fabricated using n-type thermoelectric inks, which constitutes a major advantage to be applied in printing techniques because of their low curing temperature. The device architecture was composed of 10 stripes with 0.2 × 2.5 cm2 each in a one-leg configuration. This prototype yielded a power output up to ∼9 μW cm–2 with a 46 K temperature gradient (ΔT), and the results were combined with numerical simulations showing a good match between the experimental and the numerical results. The thermoelectric devices studied in this work offer easy fabrication, flexibility, and an attractive thermoelectric output for specific power requirements such as for environmental health monitoring.

Magnetoliposomes containing superparamagnetic manganese ferrite nanoparticles were tested as nanocarriers for two new promising antitumor drugs, a N-(3-methoxyphenyl)thieno[3,2-b]pyridin-7-amine (1) and a N-(2-methoxy-phenyl)thieno[3,2-b]pyridin-7-amine (2). The fluorescence emission of both compounds was studied in different polar and non-polar media, evidencing a strong intramolecular charge transfer character of the excited state of both compounds. These in vitro potent antitumor thienopyridine derivatives were successfully incorporated in both aqueous and solid magnetoliposomes, with encapsulation efficiencies higher than 75%. The magnetic properties of magnetoliposomes containing manganese ferrite nanoparticles were measured for the first time, proving a superparamagnetic behaviour. Growth inhibition assays on several human tumor cell lines showed very low GI 50 values for drug-loaded aqueous magnetoliposomes, comparing in most cell lines with the ones previously obtained using the neat compounds. These results are important for future drug delivery applications using magnetoliposomes in oncology, through a dual therapeutic approach (simultaneous chemotherapy and magnetic hyperthermia).

Abstract

Magnesium ferrite nanoparticles, with diameters around 25 nm, were synthesized by coprecipitation method. The magnetic properties indicate a superparamagnetic behaviour, with a maximum magnetization of 16.2 emu g−1, a coercive field of 22.1 Oe and a blocking temperature of 183.2 K. These MgFe2O4 nanoparticles were used to produce aqueous and solid magnetoliposomes, with sizes below 130 nm. The potential drug curcumin was successfully incorporated in these nanosystems, with high encapsulation efficiencies (above 89%). Interaction by fusion between both types of drug-loaded magnetoliposomes (with or without PEGylation) and models of biological membranes was demonstrated, using FRET or fluorescence quenching assays. These results point to future applications of magnetoliposomes containing MgFe2O4 nanoparticles in cancer therapy, allowing combined magnetic hyperthermia and chemotherapy.

No abstract